Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies

Vaccination and administration of monoclonal antibody cocktails are effective tools to control the progression of infectious diseases and to terminate pandemics such as COVID-19. However, the emergence of SARS-CoV-2 mutants with enhanced transmissibility and altered antigenicity requires broad-spect...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Hongyu, Yuan, Xin-Yong, Cabral, Teresa, Manguiat, Kathy, Robinson, Alyssia, Wood, Heidi, Grant, Chris, McQueen, Peter, Westmacott, Garrett, Beniac, Daniel R., Lin, Lisa, Carpenter, Michael, Kobasa, Darwyn, Gräfenhan, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572761/
https://www.ncbi.nlm.nih.gov/pubmed/34762975
http://dx.doi.org/10.1016/j.antiviral.2021.105206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572761/
https://www.ncbi.nlm.nih.gov/pubmed/34762975
http://dx.doi.org/10.1016/j.antiviral.2021.105206

Ejemplares similares